Literature DB >> 1346515

Pathogenesis and treatment of portal-systemic encephalopathy: an update.

R F Butterworth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1346515     DOI： 10.1007/bf01307722

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  41 in total

1.  Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia.

Authors:  W V McDERMOTT; R D ADAMS
Journal:  J Clin Invest       Date:  1954-01       Impact factor: 14.808

2.  Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy.

Authors:  R Meier; K Gyr; A Scholer
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

3.  Chronic hepatic encephalopathy.

Authors:  W C Maddrey; F L Weber
Journal:  Med Clin North Am       Date:  1975-07       Impact factor: 5.456

4.  Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid.

Authors:  F Moroni; O Riggio; V Carlà; V Festuccia; F Ghinelli; I R Marino; M Merli; L Natali; G Pedretti; F Fiaccadori
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

5.  Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.

Authors:  M Olasmaa; J D Rothstein; A Guidotti; R J Weber; S M Paul; S Spector; M L Zeneroli; M Baraldi; E Costa
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

6.  Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat.

Authors:  M Bergeron; M S Swain; T A Reader; L Grondin; R F Butterworth
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

7.  Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  R F Butterworth; J Lavoie; J F Giguère; G Pomier-Layrargues
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

8.  Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

Authors:  G Bansky; P J Meier; E Riederer; H Walser; W H Ziegler; M Schmid
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

9.  Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease.

Authors:  P Ferenci; D F Schafer; G Kleinberger; J H Hoofnagle; E A Jones
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

10.  "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy.

Authors:  K D Mullen; K M Szauter; K Kaminsky-Russ
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321
View more
  17 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Memory impairment in patients with cirrhosis.

Authors:  Funda Bahceci; Bulent Yildirim; Melih Karincaoglu; Ibrahim Dogan; Birsen Sipahi
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

3.  Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication.

Authors:  E Kosenko; Y Kaminsky; O Lopata; N Muravyov; A Kaminsky; C Hermenegildo; V Felipo
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 4.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

5.  Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.

Authors:  R Pirisino; C Ghelardini; G Banchelli; N Galeotti; L Raimondi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 6.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

Review 7.  Liver cirrhosis.

Authors:  E J Williams; J P Iredale
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

8.  Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

Authors:  B Alexander; M Aslam; A Nobin; I S Benjamin
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

9.  Effect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resection.

Authors:  T Aono; T Sakaguchi; K Tsukada; I Kurosaki; K Hatakeyama
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

10.  Brain biopterin metabolism in chronic experimental hepatic encephalopathy.

Authors:  P B Bergqvist; E R Werner; G Apelqvist; M Bugge; H Wachter; F Bengtsson
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.